If you have been reading about anti-doping and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Last reviewed on 2026-05-05. Where a claim depends on a specific study, the study is described rather than over-claimed.
AOD-9604 has been investigated primarily as a potential treatment for obesity and related metabolic conditions. Early laboratory work examined its effects on fat cells, and later studies moved into animal models and human clinical trials. Some trials reportedly reached Phase II, but the program did not lead to an approved medicine. Published summaries often note that weight-loss results were modest or inconsistent. The full trial data are not all publicly available in detail.
Regulatory treatment of AOD-9604 has varied. In sports anti-doping, the peptide became widely discussed during a 2013 investigation into an Australian professional sports club. Authorities at the time debated whether it fell under prohibitions on growth hormone and related substances. Later clarifications and updated lists have addressed the compound in different ways. Anyone seeking current status should consult the latest applicable rules, and commercial supply for human use is not authorized in major markets.
Regulatory bodies have taken different approaches to AOD-9604. It is not approved as a prescription medicine by major agencies such as the U.S. Food and Drug Administration or the European Medicines Agency. In sport, the World Anti-Doping Agency prohibits peptide hormones, growth factors, and related substances, and AOD-9604 has been treated as a prohibited substance. These regulatory decisions reflect concerns about safety, efficacy, and potential misuse rather than proof of benefit.
Research on AOD-9604 also examines how the peptide is measured in biological samples. Analytical methods may include liquid chromatography coupled with mass spectrometry, immunoassays, or both. Detection can be challenging because the peptide is small and may be present at low concentrations. Published methods vary in sensitivity and specificity, so comparative interpretation requires attention to validation details. The presence of related hGH fragments can complicate identification in some matrices.
| Property | Value | Notes |
|---|---|---|
| Primary research area | Obesity and metabolic regulation | Studied in cell, animal, and human models |
| Highest reported trial phase | Phase II | Public summaries describe mixed results |
| Common route in trials | Subcutaneous injection | Typical for peptide therapeutics |
| Regulatory example | 2013 Australian anti-doping review | Classification was debated at the time |
| Approval status | Not approved as a human medicine | Status can change by jurisdiction |
A central uncertainty is whether observed metabolic changes translate into meaningful clinical benefits. Study designs vary in dose, duration, and participant characteristics, making comparisons difficult. Independent replication is limited, and the field lacks consensus on optimal endpoints or treatment duration. Ongoing or future studies may clarify mechanism and effect size, but current evidence does not establish a clear therapeutic role. Researchers often call for larger, longer, and better-controlled trials, while questions remain about which patient groups might respond.
Proposed mechanism focuses on lipolysis, the breakdown of stored triglycerides into free fatty acids and glycerol. AOD-9604 is thought to act on adipose tissue without stimulating appetite or affecting blood sugar in the same way as growth hormone. Laboratory studies report increased fat oxidation in some models. The precise receptor interactions and signaling pathways remain incompletely characterized. Researchers have proposed that the peptide may influence fat mobilization through pathways distinct from the full hormone.
Research has examined whether the peptide affects fat mass independently of growth hormone's other actions. Early animal studies suggested reductions in body fat, but species differences and small sample sizes limit interpretation. Human studies have generally been short and have not consistently shown large effects. Some trials measured body composition, lipid profiles, and safety parameters, but the overall picture is one of suggestive yet inconclusive metabolic activity. Findings vary across study populations and protocols.
Several names appear in scientific and commercial settings. AOD9604 and AOD-9604 are development codes used interchangeably, while hGH fragment 176-191 describes the same region. The peptide includes a disulfide bond between two cysteine residues, which helps shape its three-dimensional structure. Different suppliers may provide acetate or other salt forms, and purity can vary. These differences matter because analytical tests and biological assays can respond to the specific form being studied.
Early interest in AOD-9604 centered on whether a fragment of human growth hormone could influence fat metabolism without the broader effects of the full hormone. Cell and animal studies reported changes in fat storage and breakdown. Human trials followed, but the results were not strong enough to secure regulatory approval. The compound remains available for laboratory research, and its clinical potential is still described as uncertain. Studies continue to examine its activity and safety profile.
==== Probing pocket depth (PPD) ==== Pocket depth is the distance from the gingival margin to the base of the pocket. The position of the gingival margin can change due to swelling or recession, and vary with inflammation if force of probing, therefore, probing depth measurement alone is not recommended for assessment of changes in periodontal support over time.
== Definition == Pressure is the amount of force applied perpendicular to the surface of an object per unit area. The symbol for it is p or P. The IUPAC recommendation for pressure is a lower-case p. However, upper-case P is widely used. The usage of P versus p depends upon the field in which one is working, on the nearby presence of other symbols for quantities such as power and momentum, and on writing style.
==== July ==== On 1 July, a National Guard member was shot dead by a Syrian government sniper, the National Guard declared it was an "explicit violation" of the ceasefire. On 2 July, the Syrian government forces clashed with the National Guard after an intense bombardment by government forces in Tel Hadid, the clashes also took place in Umm al-Zaytoun and al-Matuna, in northern Suwayda. On 7 July, the Syrian government forces bombarded the city of Al-Mazra'a with mortars, sparking clashes along the Al-Majdal and Al-Mazra'a axis. On 13 July, one year after the events of July 2025, the residents of Jaramana held a meeting to commemorate the events; at the vigil, the head of the spiritual and religious authority of Jaramana, Haitham Katiba, declared Druze dignity and their right to defend themselves. On 16 July, the events of the "Black July Week" continued, commemorating fallen Druze soldiers at the Shrine of the Martyrs in the city of Ar-Raha; in addition to the arrival of people at Al-Karama Square to participate in the popular events held to commemorate the first anniversary of the "Black July Week". On 21 July, the National Guard carried out a forced eviction at the Al-Fursan residences, targeting Alawite families, while the Syrian Observatory for Human Rights claims it was a dispute between an Alawite resident and a Druze resident. On 29 July, the Israeli far-right settler movement, Pioneers of Bashan, declared that its goal is "to create a humanitarian corridor from Israel to Suwayda", after several attempts to cross the territories occupied in the Israeli invasion.
In modern-day 21st century, medicine has evolved to involve past treatments such as leech therapy, as well as advancing wound prevention and the treatment. A large part of wound care is wound treatment. This involves promoting healing, preventing infections, and getting rid of an already existent infection. Deciding on a treatment depends on the type of wound that a person has sustained. Varying from infections to burns, wound care is a priority in saving the limb, extremity, or life of a person. In a hospital or medical care setting, more severe wounds like diabetic ulcers, decubitus ulcers, and burns require sterile or clean (depending on the severity of the wound) dressings and wound care. The types of wound dressing include: dry dressings, wet-to-dry dressings, chemical-impregnated dressings, foam dressings, alginate dressings, hydrofiber dressings, transparent film dressings, hydrogel dressings, and hydrocolloid dressings. All of the listed dressing types require different materials to complete the dressing.
Sources: en.wikipedia.org
=== Color === Whiteness of tofu is determined by soybean variety, soybean protein composition, and degree of aggregation of the tofu gel network. The yellowish-beige color of soybeans is due to the color compounds including anthocyanin, isoflavones, and polyphenol compounds; therefore the soybean variety used will predicate the color of the final tofu product. Ways to reduce the yellow color include reducing isoflavone content by changing the pH of the soy milk solution used in the production of the tofu so that the relevant compounds precipitate out and are removed during the extraction of okara. The opacity of tofu gel and the off-white color typical of standard uncooked firm tofu is due to the scattering of light by the colloidal particles of the tofu. The addition of higher levels of calcium salts or a high protein content will contribute to forming a denser and more aggregated gel network which disperses more light, resulting in tofu with a whiter appearance.
reduced riboflavin + NADP+ Thus, the two products of this enzyme are reduced riboflavin and NADP+, whereas its 3 substrates are riboflavin, NADPH, and H+. This enzyme belongs to the family of oxidoreductases, specifically those acting on the CH-NH group of donors with NAD+ or NADP+ as acceptor. The systematic name of this enzyme class is reduced-riboflavin:NADP+ oxidoreductase. Other names in common use include flavine mononucleotide (FMN) reductase, FMN reductase (NADPH), NADPH-dependent FMN reductase, NADPH-flavin reductase, NADPH-FMN reductase, NADPH-specific FMN reductase, NADPH2 dehydrogenase (flavin), NADPH2:riboflavin oxidoreductase, NADPH:flavin oxidoreductase, riboflavin mononucleotide reductase, riboflavine mononucleotide reductase and riboflavin mononucleotide (reduced nicotinamide adenine dinucleotide, phosphate) reductase.
=== Xander Lindt === Xander Lindt (Gustav Lindh) is a cocky young heir of the Lindt chocolate empire, and a member of Henry's entourage. He repeatedly demeans Yasmin after she rejects his sexual advances at a Swiss climate conference.
== Diagnosis == The history of a preceding influenza-like infection followed by the typical symptoms of acute onset of symmetrical calf pain and gait problems together with an isolated finding of a high level of creatine kinase suggests the diagnosis of BACM. Myoglobinuria is rare and points to the possibility of the development of rhabdomyolysis and kidney failure. Guillain-Barré syndrome (GBS) is the main consideration in the differential diagnosis. It needs to be quickly excluded as early intervention in GBS is indicated. Other conditions under possible consideration are dermatomyositis, muscular dystrophy, juvenile idiopathic arthritis, transient synovitis of the hip, osteomyelitis, and myalgia. Few muscle biopsies have been conducted. Results may show normal findings or features of inflammation and necrosis.
Bomb defusal: The Terrorist team has a bomb when the round starts. The goal of the Terrorists is to plant the bomb at a bomb site—maps generally have two called Bombsite A and Bombsite B—and ensure the bomb goes off after a short timer. The Counter-Terrorist team wins if they are able to defuse the bomb within a set time limit or if the time runs out before the bomb is planted. The Terrorist team wins if the bomb successfully detonates. If either team is eliminated before the bomb is planted or the rounds ends, the other team wins. Bomb defusal maps start with the prefix "de_" (e.g de_dust2). Hostage rescue: Hostages (non-player characters) are located on the map, generally close to the Terrorist spawn point. The goal of the Counter-Terrorist team is to collect hostages and run to a location on the map where they are rescued. Either team may also win if every member of the opposing team is eliminated. The Terrorists win if the round ends due to timing out. Maps with this objective start with the prefix "cs_" (e.g cs_office). Assassination: In this game mode, one Counter-Terrorist member becomes a VIP, armed with a Counter-Terrorist standard-issue USP handgun. The VIP is not permitted to retrieve dropped firearms except their own handgun. Either all the Terrorists die or the VIP must enter an extraction zone within a time limit for the Counter-Terrorists to win. The Terrorists win if the VIP dies or the time limit runs out. Maps with this objective start with the prefix "as_".
Sources: en.wikipedia.org
No major medicines regulator appears to have approved AOD-9604 for human therapeutic use. It has been studied in clinical trials, but those programs did not result in a marketed drug.
It became prominent during a 2013 Australian sports investigation that examined whether it was a prohibited growth-hormone-related substance. Subsequent interpretations and list updates have varied, so current rules should be checked directly.
Published summaries generally report limited or inconsistent weight-loss effects, and complete trial data are not widely available. The studies were not sufficient to establish it as an effective obesity treatment.
No. It is not approved as a therapeutic drug by major regulators. It is sold for research purposes in many settings, which is not the same as clinical approval.